Breaking News
45 minutes ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Novartis Q1 2026 regulatory milestones across immunology and neuromuscular assets signal mounting CMC and supply chain demands for the remainder of the year.
Pharma Now Editorial Team

Survodutide hits Phase III co-primary endpoints with 16.6% weight loss, intensifying manufacturing and regulatory planning demands.
Pharma Now Editorial Team

Piramal Pharma Solutions appoints Gregory Judge as Director to lead large-molecule biologics partnerships across Europe.
Pharma Now Editorial Team

Samsung Bioepis Q2 2026 report records 92 US biosimilar approvals, signaling tighter interchangeability and QA demands for manufacturers.
Pharma Now Editorial Team
